BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1665230)

  • 1. [Endocrine cells in pancreatic cancers: importance for grading and prognosis?].
    Görgen-Mahler B; Saeger W; Dziwisch L
    Pathologe; 1991 Nov; 12(6):306-10. PubMed ID: 1665230
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microglandular pancreatic cancer. Histological, immunocytochemical and electron microscopy findings].
    Stömmer P; Kraus J; Langer E
    Pathologe; 1989 Nov; 10(6):354-8. PubMed ID: 2556695
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spindle cell carcinoma of the pancreas: a case report with immunohistologic study].
    Dworák O; Kessler H; Riedel C
    Pathologe; 1992 Jul; 13(4):221-3. PubMed ID: 1380712
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic endocrine tumors: diagnostic pitfalls.
    Ectors N
    Hepatogastroenterology; 1999; 46(26):679-90. PubMed ID: 10370596
    [No Abstract]   [Full Text] [Related]  

  • 5. [The functionally inactive endocrine pancreas tumor].
    Meyer D; Engemann R; Marx A; Thiede A
    Chirurg; 1994 Oct; 65(10):856-60. PubMed ID: 7821044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell receptors and proliferation markers in breast cancer].
    Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
    Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endocrine pancreatic tumor with Cushing syndrome and hypergastrinemia].
    Höring E; Richter G; Kratzer U; Hamperl WD; Wienbeck M
    Internist (Berl); 1989 Sep; 30(9):614-8. PubMed ID: 2553637
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endocrine differentiated prostate cancer. Histology and immunohistochemistry].
    Helpap B; Oehler U; Bollmann R
    Pathologe; 1990 Jan; 11(1):18-24. PubMed ID: 1690418
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostically relevant factors in ductal pancreatic cancer].
    Böttger T; Zech J; Weber W; Sorger K; Junginger T
    Chirurg; 1989 Aug; 60(8):521-8. PubMed ID: 2551604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Scirrhous adenocarcinoma of the pancreas].
    Eshutkin GD
    Vopr Onkol; 1972; 18(1):28-36. PubMed ID: 4335944
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer (non-endocrine) of the pancreas. A suggested classification.
    Cubilla AL; Fitzgerald PJ
    Monogr Pathol; 1980; 21():82-110. PubMed ID: 6261124
    [No Abstract]   [Full Text] [Related]  

  • 12. [A rare case of an isolated metastasis of the head of the pancreas of a breast cancer with obstruction of the efferent bile ducts].
    Hardt W; Parent B; Januschka J; Morath R
    Pathologe; 1993 May; 14(3):167-71. PubMed ID: 8390657
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
    Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
    Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proteohormones as markers of malignant tumors. Paraneoplastic endocrine syndromes].
    Hrnciar J; Hrnciarová M; Zúbek V; Hornová V; Korbacková R
    Vnitr Lek; 1987 Oct; 33(10):910-8. PubMed ID: 3686841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantitative DNA measurements of ductal pancreatic cancers: comparison of the DNA content with histology, rate of survival, grading and staging].
    Weger AR; Graf AH; Askensten U; Schwab G; Bodner E; Auer G; Mikuz G
    Verh Dtsch Ges Pathol; 1987; 71():126-9. PubMed ID: 2830735
    [No Abstract]   [Full Text] [Related]  

  • 17. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations.
    Tomaszewska R; Nowak K; Stachura J
    Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
    Hiraoka N; Onozato K; Kosuge T; Hirohashi S
    Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of endocrine pancreatic tumors].
    Schöber C; Galanski M; Jörgensen M; Schmoll HJ
    Wien Med Wochenschr; 1997; 147(1):18-23. PubMed ID: 9133102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic syndromes in cancer: Case 1. Polycythemia as a result of ectopic erythropoietin production in metastatic pancreatic carcinoid tumor.
    Samyn I; Fontaine C; Van Tussenbroek F; Pipeleers-Marichal M; De Grève J
    J Clin Oncol; 2004 Jun; 22(11):2240-2. PubMed ID: 15169813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.